ID: ALA610554

Max Phase: Preclinical

Molecular Formula: C12H19N4O9P

Molecular Weight: 394.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](NP(=O)(O)OC[C@H]1OC(n2ccc(N)nc2=O)[C@H](O)[C@@H]1O)C(=O)O

Standard InChI:  InChI=1S/C12H19N4O9P/c1-5(11(19)20)15-26(22,23)24-4-6-8(17)9(18)10(25-6)16-3-2-7(13)14-12(16)21/h2-3,5-6,8-10,17-18H,4H2,1H3,(H,19,20)(H2,13,14,21)(H2,15,22,23)/t5-,6+,8+,9+,10?/m0/s1

Standard InChI Key:  UUEQDEICBVKJIL-TZMJUOFKSA-N

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 394.28Molecular Weight (Monoisotopic): 394.0890AlogP: -2.38#Rotatable Bonds: 7
Polar Surface Area: 206.46Molecular Species: ACIDHBA: 10HBD: 6
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.43CX Basic pKa: CX LogP: -3.23CX LogD: -8.95
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.27Np Likeness Score: 1.18

References

1. Whalen LJ, McEvoy KA, Halcomb RL..  (2003)  Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.,  13  (2): [PMID:12482445] [10.1016/s0960-894x(02)00735-7]

Source